Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Recurrent sterile abscesses following aluminium adjuvant-containing vaccines.

Klein NP, Edwards KM, Sparks RC, Dekker CL; Clinical Immunization Safety Assessment (CISA) Network.

BMJ Case Rep. 2009;2009. pii: bcr09.2008.0951. doi: 10.1136/bcr.09.2008.0951. Epub 2009 Mar 17.

2.

Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.

LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA.

Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18.

PMID:
21502239
3.

Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence.

Jefferson T, Rudin M, Di Pietrantonj C.

Lancet Infect Dis. 2004 Feb;4(2):84-90. Review.

PMID:
14871632
4.

Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.

Salmon DA, Moulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA.

Pediatrics. 2004 Jun;113(6):e552-9.

PMID:
15173536
5.

Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity.

Graham BS, McElrath MJ, Keefer MC, Rybczyk K, Berger D, Weinhold KJ, Ottinger J, Ferarri G, Montefiori DC, Stablein D, Smith C, Ginsberg R, Eldridge J, Duerr A, Fast P, Haynes BF; AIDS Vaccine Evaluation Group.

PLoS One. 2010 Aug 10;5(8):e11995. doi: 10.1371/journal.pone.0011995.

6.

Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination.

Stetler HC, Garbe PL, Dwyer DM, Facklam RR, Orenstein WA, West GR, Dudley KJ, Bloch AB.

Pediatrics. 1985 Feb;75(2):299-303.

PMID:
3881728
7.

Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.

Williams SE, Klein NP, Halsey N, Dekker CL, Baxter RP, Marchant CD, LaRussa PS, Sparks RC, Tokars JI, Pahud BA, Aukes L, Jakob K, Coronel S, Choi H, Slade BA, Edwards KM.

Vaccine. 2011 Sep 16;29(40):6920-7. doi: 10.1016/j.vaccine.2011.07.044. Epub 2011 Jul 27. Review.

PMID:
21801776
8.

Children who received PCV-10 vaccine from a two-dose vial without preservative are not more likely to develop injection site abscess compared with those who received pentavalent (DPT-HepB-Hib) vaccine: a longitudinal multi-site study.

Berhane Y, Worku A, Demissie M, Tesfaye N, Asefa N, Aniemaw W, Weldearegawi B, Kebede Y, Shiferaw T, Worku A, Olijira L, Merdekios B, Ashebir Y, Tadesse T, Dessie Y, Meseret S, Ayele G.

PLoS One. 2014 Jun 4;9(6):e97376. doi: 10.1371/journal.pone.0097376. eCollection 2014.

9.

Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.

Dodoo AN, Renner L, van Grootheest AC, Labadie J, Antwi-Agyei KO, Hayibor S, Addison J, Pappoe V, Appiah-Danquah A.

Drug Saf. 2007;30(4):347-56.

PMID:
17408311
10.
11.

Recurrent Sterile Abscesses After Immunization With Aluminum-Adjuvant Based Vaccines.

Vargas KM, Koil A, Dehority W.

Clin Pediatr (Phila). 2017 Sep 1:9922817728702. doi: 10.1177/0009922817728702. [Epub ahead of print] No abstract available.

PMID:
28868897
12.

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, Li RC, Xia SL, Zhao YL, Li FJ, Yan SH, Yin WD, An K, Feng DJ, Cui XL, Qi FC, Ju CJ, Zhang YH, Guo ZJ, Chen PY, Chen Z, Yan KM, Wang Y.

Lancet. 2010 Jan 2;375(9708):56-66. doi: 10.1016/S0140-6736(09)62003-1. Epub 2009 Dec 15. Erratum in: Lancet. 2010 May 15;375(9727):1694.

PMID:
20018364
14.

[Comparative clinical trial of vaccines against avian influenza].

Zverev VV, Katlinskiĭ AV, Kostinov MP, Zhirova SN, Erofeeva MK, Stukova MA, Korovkin SA, Mel'nikov SIa, Semchenko AV, Mironov AN.

Zh Mikrobiol Epidemiol Immunobiol. 2007 May-Jun;(3):10-6. Russian.

PMID:
17672124
15.

Effect of Fusobacterium necrophorum leukotoxoid vaccine on susceptibility to experimentally induced liver abscesses in cattle.

Saginala S, Nagaraja TG, Lechtenberg KF, Chengappa MM, Kemp KE, Hine PM.

J Anim Sci. 1997 Apr;75(4):1160-6.

16.

Risk factors for improper vaccine storage and handling in private provider offices.

Bell KN, Hogue CJ, Manning C, Kendal AP.

Pediatrics. 2001 Jun;107(6):E100.

PMID:
11389298
17.

Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.

Knuf M, Habermehl P, Faber J, Bock HL, Sänger R, Bogaerts H, Clemens R, Schuind A, du Prel JB, Schmitt HJ.

Vaccine. 2006 Jul 7;24(27-28):5627-36. Epub 2006 May 2.

PMID:
16740348
18.

Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination.

Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, Halsey N, Klein NP, Baxter RP, Marchant CD, Larussa PS, Barnett ED, Tokars JI, McGeeney BE, Sparks RC, Aukes LL, Jakob K, Coronel S, Sejvar JJ, Slade BA, Edwards KM.

Vaccine. 2011 Oct 26;29(46):8302-8. doi: 10.1016/j.vaccine.2011.08.093. Epub 2011 Sep 3.

19.

Immunoglobulin E and G responses to pertussis toxin in children immunised with adsorbed and non-adsorbed whole cell pertussis vaccines.

Duchén K, Granström M, Hedenskog S, Blennow M, Björkstén B.

Vaccine. 1997 Oct;15(14):1558-61.

PMID:
9330468
20.

A cell culture vaccine against bovine ephemeral fever.

Tzipori S, Spradbrow PB.

Aust Vet J. 1978 Jul;54(7):323-8.

PMID:
708328

Supplemental Content

Support Center